Healthcare company DexCom, Inc. (NASDAQ: DXCM) reported a double-digit increase in second-quarter earnings and also provided full-year guidance.
- Second-quarter revenue grew 25% year-over-year to $871.3 million, on a reported basis, and 26% on an organic basis
- U.S. revenue rose 21%; international revenue increased 38% on a reported basis and 40% on an organic basis
- Operating income increased sharply to $128.1 million in Q2 from $77.0 million in the prior-year quarter
- Q2 net income was $115.9 million or $0.28 per share, compared to $50.9 million or $0.12 per share in the same quarter of 2022
- As of June 30, Dexcom held $3.64 billion in cash, cash equivalents, and marketable securities
- For fiscal 2023, the management expects total revenue to be in the range of $3.500 billion to 3.550 billion, which represents a 20-22% growth
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Accenture (ACN) to report Q2 2025 results Thursday. Here’s what to expect
Accenture plc, (NYSE: ACN) is preparing to publish its second-quarter results this week, amid expectations for a year-over-year increase in revenue and profit. The professional services company had a strong
What to expect when Dollar Tree (DLTR) reports Q4 2024 earnings results
Shares of Dollar Tree, Inc. (NASDAQ: DLTR) gained over 1% on Monday. The stock has dropped 6% over the past three months. The discount store chain is scheduled to report
MU Earnings Preview: Strong Q2 results in cards amid growing AI demand
Micron Technology, Inc. (NASDAQ: MU) is uniquely positioned to capitalize on the AI wave sweeping the tech industry, leveraging its high-bandwidth-memory products designed for massive data processing tasks. The company
